Larimar Therapeutics (LRMR) Debt Ratio (2014 - 2020)

Larimar Therapeutics (LRMR) has reported Debt Ratio for 7 consecutive years, with 0.19 the latest figure, recorded in Q1 2020.

• For the quarter ending Q1 2020, Debt Ratio rose 0.77% year-over-year to 0.19; the trailing twelve-month figure through Mar 2020 stood at 0.19 (up 0.77% YoY), and the FY2019 full-year result was 3.03, up 1685.0% from the prior year.
• Debt Ratio fell to 0.19 in Q1 2020 per LRMR's latest filing, from 3.03 in the prior quarter.
• Across five years, Debt Ratio topped out at 3.03 in Q4 2019 and bottomed at 0.01 in Q3 2017.
• Historically, Debt Ratio has averaged 0.29 across 5 years, with a median of 0.18 in 2018.
• The sharpest annual moves came in 2017 and 2019: Debt Ratio slumped 56.48% in 2017, then jumped 1685.0% in 2019.
• Over 5 years, Debt Ratio stood at 0.03 in 2016, then surged by 595.17% to 0.19 in 2017, then fell by 10.57% to 0.17 in 2018, then surged by 1685.0% to 3.03 in 2019, then sank by 93.71% to 0.19 in 2020.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.19, 3.03, and 0.19 for Q1 2020, Q4 2019, and Q3 2019 respectively.